银化物Rg1减轻慢性睡眠不足引起的海马线粒体功能障碍,并通过AMPK-SIRT3途径改善记忆力
Ning Jiang1, Caihong Yao1, Yiwen Zhang1
1Research Center for Pharmacology and Toxicology, Institute of Medicinal Plant Development (IMPLAD), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
金色化物Rg1 (Rg1) 有效地对抗慢性睡眠不足压力 (CSDS) 的认知缺陷. 它通过减少氧化应激和改善线粒体健康来增强记忆力和大脑功能.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 慢性睡眠不足压力 (CSDS) 是认知障碍的一个重要原因.
- 人参的一个关键成分,人参代Rg1 (Rg1) 显示出减轻神经损伤的潜力.
研究的目的:
- 研究Rg1对CSDS引起的认知缺陷的治疗效果.
- 阐明Rg1作用的潜在分子机制.
主要方法:
- 用行为测试来评估空间工作和识别记忆.
- 通过RNA测序分析的基因表达变化.
- 生物化学测定测量了氧化应激标志物 (SOD,CAT,MDA) 和蛋白质水平 (Nrf2,HO-1,Mfn2,Drp-1,AMPK,SIRT3,裂开的卡斯帕酶-3).
- 评估了线粒体功能和亡.
主要成果:
- 在CSDS模型中,Rg1治疗显著改善了记忆性能.
- Rg1调节了代谢途径,减少了氧化应激,增强了抗氧化酶活性.
- Rg1恢复了海马线粒体的结构和功能,调节了Mfn2和Drp-1等关键蛋白质.
- 通过改变Bax/Bcl-2比率和caspase-3活性,Rg1抑制了神经元亡.
- 在Rg1上调节AMPK和SIRT3,这对细胞能量和线粒体平衡至关重要.
结论:
- 金色化物Rg1在治疗与睡眠剥夺相关的认知功能障碍方面具有显著的潜力.
- Rg1通过准线粒体功能障碍,氧化应激,亡以及AMPK-SIRT3信号通路来发挥其神经保护作用.
更多相关视频
08:44Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
07:04A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats
Published on: August 19, 2018
相关概念视频
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Management of Insomnia
